Overview

Bilirubin Neurotoxicity (BN) and Neurodevelopmental Impairment (NDI) in Extremely Preterm (EP) Infants: Avoidable by Reducing the Usual Intravenous Lipid (UL) Administration

Status:
Recruiting

Trial end date:
2025-01-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the effect of Usual versus Reduced Lipid Intake on Unbound Bilirubin Levels, Brainstem Auditory Evoked Potentials, and neurodevelopmental Outcome at 2 Years in Extremely Preterm Infants

Phase:

Phase 2

Details

Lead Sponsor:

The University of Texas Health Science Center, Houston

Treatments:

Soybean oil, phospholipid emulsion